FI111948B - Uudet tetrasykliset piperidiini- ja 1,4-oksatsiiniyhdisteet - Google Patents
Uudet tetrasykliset piperidiini- ja 1,4-oksatsiiniyhdisteet Download PDFInfo
- Publication number
- FI111948B FI111948B FI952802A FI952802A FI111948B FI 111948 B FI111948 B FI 111948B FI 952802 A FI952802 A FI 952802A FI 952802 A FI952802 A FI 952802A FI 111948 B FI111948 B FI 111948B
- Authority
- FI
- Finland
- Prior art keywords
- ppm
- formula
- compound
- compounds
- trans
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, ***e
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9406985A FR2721027B1 (fr) | 1994-06-08 | 1994-06-08 | Nouveaux dérivés tétracycliques de la 1,4-oxazine, leur procédé de préparation et les compositions pharmaceutiques les contenant. |
FR9406985 | 1994-06-08 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI952802A0 FI952802A0 (fi) | 1995-06-07 |
FI952802A FI952802A (fi) | 1995-12-09 |
FI111948B true FI111948B (fi) | 2003-10-15 |
Family
ID=9463983
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI952802A FI111948B (fi) | 1994-06-08 | 1995-06-07 | Uudet tetrasykliset piperidiini- ja 1,4-oksatsiiniyhdisteet |
Country Status (17)
Country | Link |
---|---|
US (2) | US5593989A (de) |
EP (1) | EP0686637B1 (de) |
JP (1) | JP3157418B2 (de) |
CN (1) | CN1050358C (de) |
AT (1) | ATE192155T1 (de) |
AU (1) | AU681780B2 (de) |
CA (1) | CA2151096C (de) |
DE (1) | DE69516457T2 (de) |
DK (1) | DK0686637T3 (de) |
ES (1) | ES2147825T3 (de) |
FI (1) | FI111948B (de) |
FR (1) | FR2721027B1 (de) |
GR (1) | GR3033762T3 (de) |
NO (1) | NO304741B1 (de) |
NZ (1) | NZ272298A (de) |
PT (1) | PT686637E (de) |
ZA (1) | ZA954738B (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2741074B1 (fr) * | 1995-11-09 | 1997-12-19 | Adir | Nouveaux composes tetracycliques de la 1,4-oxazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
EP0988289A2 (de) * | 1997-06-05 | 2000-03-29 | Takeda Pharmaceutical Company Limited | Benzofurane und benzothiophene als unterdrücker der neurodegeneration |
EP1615906A1 (de) * | 2003-04-03 | 2006-01-18 | Vertex Pharmaceuticals Incorporated | Zusammensetzungen, die sich als inhibitoren von proteinkinasen eignen |
FR2906249B1 (fr) * | 2006-09-26 | 2008-12-19 | Servier Lab | Composes tetracycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1204745A (en) * | 1981-11-20 | 1986-05-20 | Merck Co. | Hexahydronaphth (1,2-b) -1,4 -oxazines |
US4420480A (en) * | 1981-11-20 | 1983-12-13 | Merck & Co., Inc. | Hexahydronaphth[1,2-b]-1,4-oxazines |
US4435231A (en) * | 1982-03-31 | 1984-03-06 | The United States Of America As Represented By The United States Department Of Energy | Cold worked ferritic alloys and components |
DE3583307D1 (en) | 1984-05-10 | 1991-08-01 | Ciba Geigy Ag | Benzo-(pyrano und thiopyrano)-pyridine. |
US4774243A (en) * | 1985-12-24 | 1988-09-27 | Merck & Co., Inc. | Dopamine agonists for treating elevated intraocular pressure |
US4792548A (en) * | 1986-05-21 | 1988-12-20 | Warner-Lambert Company | Trans-benzopyran-(4,3-b)-1,4-oxazine derivatives, intermediates and pharmaceutical use |
US5294618A (en) * | 1989-07-28 | 1994-03-15 | Merck Sharp & Dohme Limited | Octahydrobenzisoquinoline derivatives as antipsychotic agents |
WO1993024471A1 (en) | 1992-06-02 | 1993-12-09 | Whitby Research, Inc. | Substituted naphthoxazines useful as dopaminergics |
-
1994
- 1994-06-08 FR FR9406985A patent/FR2721027B1/fr not_active Expired - Lifetime
-
1995
- 1995-06-01 US US08/456,504 patent/US5593989A/en not_active Expired - Fee Related
- 1995-06-06 AU AU20523/95A patent/AU681780B2/en not_active Ceased
- 1995-06-06 CA CA002151096A patent/CA2151096C/fr not_active Expired - Fee Related
- 1995-06-07 FI FI952802A patent/FI111948B/fi not_active IP Right Cessation
- 1995-06-07 DK DK95401311T patent/DK0686637T3/da active
- 1995-06-07 DE DE69516457T patent/DE69516457T2/de not_active Expired - Fee Related
- 1995-06-07 PT PT95401311T patent/PT686637E/pt unknown
- 1995-06-07 AT AT95401311T patent/ATE192155T1/de not_active IP Right Cessation
- 1995-06-07 ES ES95401311T patent/ES2147825T3/es not_active Expired - Lifetime
- 1995-06-07 NZ NZ272298A patent/NZ272298A/en unknown
- 1995-06-07 EP EP95401311A patent/EP0686637B1/de not_active Expired - Lifetime
- 1995-06-07 NO NO952249A patent/NO304741B1/no not_active IP Right Cessation
- 1995-06-07 CN CN95107344A patent/CN1050358C/zh not_active Expired - Fee Related
- 1995-06-08 ZA ZA954738A patent/ZA954738B/xx unknown
- 1995-06-08 JP JP14177295A patent/JP3157418B2/ja not_active Expired - Fee Related
-
1996
- 1996-06-06 US US08/659,267 patent/US5668142A/en not_active Expired - Fee Related
-
2000
- 2000-06-23 GR GR20000401458T patent/GR3033762T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2151096A1 (fr) | 1995-12-09 |
CN1050358C (zh) | 2000-03-15 |
NO952249L (no) | 1995-12-11 |
GR3033762T3 (en) | 2000-10-31 |
ATE192155T1 (de) | 2000-05-15 |
ES2147825T3 (es) | 2000-10-01 |
FR2721027A1 (fr) | 1995-12-15 |
US5593989A (en) | 1997-01-14 |
CA2151096C (fr) | 2003-07-08 |
FI952802A (fi) | 1995-12-09 |
EP0686637A1 (de) | 1995-12-13 |
CN1120541A (zh) | 1996-04-17 |
AU681780B2 (en) | 1997-09-04 |
EP0686637B1 (de) | 2000-04-26 |
AU2052395A (en) | 1995-12-14 |
DK0686637T3 (da) | 2000-09-18 |
JP3157418B2 (ja) | 2001-04-16 |
NZ272298A (en) | 1996-05-28 |
NO952249D0 (no) | 1995-06-07 |
FI952802A0 (fi) | 1995-06-07 |
US5668142A (en) | 1997-09-16 |
PT686637E (pt) | 2000-08-31 |
NO304741B1 (no) | 1999-02-08 |
JPH07330778A (ja) | 1995-12-19 |
FR2721027B1 (fr) | 1996-07-19 |
DE69516457T2 (de) | 2001-01-18 |
DE69516457D1 (de) | 2000-05-31 |
ZA954738B (en) | 1996-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5296482A (en) | (Benzocycloalkyl) alkylamines | |
FI95246C (fi) | Menetelmä terapeuttisesti käyttökelpoisten, substituoitujen aminometyylibentsodihydropyraanien ja aminometyyli(di- ja tetra)hydronaftaleenien valmistamiseksi | |
JPWO2002074746A1 (ja) | ベンゾアゼピン誘導体 | |
CN113429387B (zh) | 一种苯并[b]硒吩类STING调控剂、其制备方法及用途 | |
NZ535950A (en) | Polycyclic compounds as potent alpha2-adrenoceptor antagonists | |
KR101158976B1 (ko) | 오렉신 길항제로서의 헤테로사이클 | |
FI111948B (fi) | Uudet tetrasykliset piperidiini- ja 1,4-oksatsiiniyhdisteet | |
WO2006061126A2 (en) | Dibenzoxazepinone derivatives | |
WO2018083171A1 (en) | Spiro-compounds as s1p modulators | |
SK361292A3 (en) | Piperidylmethyl-substituted chroman derivatives, process for producing them, their use and pharmaceutical composition containg same | |
FI86301B (fi) | Foerfarande foer framstaellning av farmaceutiskt anvaendbara naftoxaziner. | |
AU616608B2 (en) | 4,5,6,7-tetrasubstituted benzoxazolones | |
AU709192B2 (en) | New tetracyclic 1,4-oxazine compounds, a process for their preparation and pharmaceutical compositions containing them | |
CS215038B2 (en) | Method of making the hexahydro-1,4-oxazepins | |
AU6289000A (en) | Novel fluorinated imidazoline benzodioxane, preparation and therapeutic uses thereof | |
MXPA01008294A (es) | Compuestos agonistas del receptor de dopamina d1. | |
GB2055372A (en) | Texahydro-trans-pyridoindole neuroleptic agents | |
JPH07165736A (ja) | ナフトキサジン類 | |
US7320973B2 (en) | Dihydrodiaryloxazepine derivative and pharmaceutical composition containing the same | |
WO2022215754A1 (ja) | 二環性ピリジン誘導体 | |
CA2706171A1 (en) | Fused indane compound | |
Bartsch et al. | Studies on the chemistry of 1, 4‐oxazines. 18. Synthesis of tricyclic 1, 4‐benzoxazines via nucleophilic substitution of activated precursors | |
CN115108986A (zh) | 阿朴菲衍生物及其制备方法和应用 | |
US3583975A (en) | Substituted octamethyleneimines | |
EA007950B1 (ru) | Способ и промежуточные соединения для получения оланзапина |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MA | Patent expired |